Hegedüs, L.; Qaisieh, S.; Stülpnagel, C.; Ganjeh Khor Dezfouli, Y.; Tambo, W.; Doerr, F.; Baldes, N.; Theegarten, D.; Schuler, M.; Bölükbas, S.;
et al. Dual HDAC and PI3K Inhibitor CUDC-907 Inhibits Growth of Pleural Mesothelioma: The Impact of Cisplatin Sensitivity and Myc Expression. Cells 2025, 14, 1599.
https://doi.org/10.3390/cells14201599
AMA Style
Hegedüs L, Qaisieh S, Stülpnagel C, Ganjeh Khor Dezfouli Y, Tambo W, Doerr F, Baldes N, Theegarten D, Schuler M, Bölükbas S,
et al. Dual HDAC and PI3K Inhibitor CUDC-907 Inhibits Growth of Pleural Mesothelioma: The Impact of Cisplatin Sensitivity and Myc Expression. Cells. 2025; 14(20):1599.
https://doi.org/10.3390/cells14201599
Chicago/Turabian Style
Hegedüs, Luca, Silvia Qaisieh, Christian Stülpnagel, Yavar Ganjeh Khor Dezfouli, Winny Tambo, Fabian Doerr, Natalie Baldes, Dirk Theegarten, Martin Schuler, Servet Bölükbas,
and et al. 2025. "Dual HDAC and PI3K Inhibitor CUDC-907 Inhibits Growth of Pleural Mesothelioma: The Impact of Cisplatin Sensitivity and Myc Expression" Cells 14, no. 20: 1599.
https://doi.org/10.3390/cells14201599
APA Style
Hegedüs, L., Qaisieh, S., Stülpnagel, C., Ganjeh Khor Dezfouli, Y., Tambo, W., Doerr, F., Baldes, N., Theegarten, D., Schuler, M., Bölükbas, S., & Hegedüs, B.
(2025). Dual HDAC and PI3K Inhibitor CUDC-907 Inhibits Growth of Pleural Mesothelioma: The Impact of Cisplatin Sensitivity and Myc Expression. Cells, 14(20), 1599.
https://doi.org/10.3390/cells14201599
_Wang.png)
